In human CD19/BCMA/CD3 transgenic mouse models, IBI3055 induces deep depletion of B cells and plasma cells in peripheral blood, spleen, lymph nodes, and bone marrow, along with significant reductions ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

In 2019, Colorado Gov. Jared Polis, the first openly gay governor elected in the U.S., signed a bill banning conversion ...

FDA expands obesity treatment options with approval of oral semaglutide (Wegovy) and orforglipron (Foundayo), shifting GLP-1 therapy from weekly injections to daily pills.

Courtly Observations is a recurring series by Erwin Chemerinsky that focuses on what the Supreme Court’s decisions will mean ...

Ro is expanding its weight-loss offering with the addition of Eli Lilly’s newly approved oral GLP-1, Foundayo (orforglipron), ...

Eli Lilly and Company (NYSE:LLY) said that its new oral medication Foundayo (orforglipron) is now available in the United ...

A regimen combining oral flavonoids and bromelain with topical lidocaine is linked to better symptom improvement and outcomes ...

ACCG-2671 is an oral small molecule amylin receptor agonist which acts through complementary satiety pathways in the ...

Topline results expected within a month and may complement positive results of a study of crofelemer for treatment of ...

Croydon has confirmed the availability of consultation appointments for patients considering porcelain veneer treatment in ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...